Empowering Young Cancer Patients: The Essential Role of Fertility Preservation Discussions

A cancer diagnosis is a life-altering event, especially for adolescents and young adults (AYAs) who are navigating pivotal life stages. Beyond the immediate concern of treating the disease, there’s a critical aspect that often goes unaddressed: future fertility. Alarmingly, recent studies reveal that only about half of young cancer patients are informed about fertility preservation options by their healthcare providers. This gap underscores the urgent need for proactive discussions and interventions to safeguard reproductive potential.

The Current Landscape

Each year, approximately 90,000 AYAs in the United States are diagnosed with cancer. Despite advancements in treatment leading to improved survival rates, many of these young survivors face the possibility of infertility due to the gonadotoxic effects of cancer therapies. A recent study highlighted that only 50.7% of patients reported having discussions about fertility preservation with their healthcare providers before initiating treatment.

Barriers to Communication

Several factors contribute to the lack of fertility preservation discussions:

• Awareness and Training: Not all oncologists are fully versed in the reproductive implications of cancer treatments or the available preservation methods.
• Time Constraints: The urgency to commence cancer treatment can overshadow conversations about future fertility.
• Assumptions About Patient Priorities: Providers may mistakenly believe that survival is the sole focus, not recognizing the importance of future family planning to many patients.

The Importance of Early Intervention

Initiating fertility preservation discussions at diagnosis is paramount. Early intervention allows for a broader range of options and better outcomes. The American Society of Clinical Oncology (ASCO) recommends that all healthcare providers address potential infertility with patients of reproductive age and offer referrals to reproductive specialists as early as possible.

Fertility Preservation Options

Various methods are available to preserve fertility in young cancer patients:

• For Females:
  • Embryo Cryopreservation: Harvesting eggs, fertilizing them with sperm, and freezing the embryos for future use.
  • Egg Freezing (Oocyte Cryopreservation): Retrieving and freezing unfertilized eggs.
  • Ovarian Tissue Freezing: Removing and freezing ovarian tissue for re-implantation post-treatment.
  • Ovarian Suppression: Using medications to protect the ovaries during chemotherapy.
• For Males:
  • Sperm Cryopreservation: Collecting and freezing sperm samples.

It’s essential to tailor these options based on individual circumstances, including age, type of cancer, and treatment plan.

The Role of Healthcare Providers

Healthcare providers play a pivotal role in bridging the information gap:

• Proactive Communication: Initiate conversations about fertility preservation as part of the standard care protocol for young patients.
• Multidisciplinary Approach: Collaborate with reproductive specialists to provide comprehensive care and up-to-date information.
• Educational Resources: Equip patients with accessible information to make informed decisions about their reproductive futures.

Empowering Patients Through Awareness

For patients, being informed is empowering:

• Ask Questions: Don’t hesitate to discuss fertility concerns with your healthcare team.
• Seek Referrals: Consult reproductive endocrinologists or fertility specialists early in the treatment planning process.
• Explore Financial Support: Investigate insurance coverage and financial assistance programs for fertility preservation procedures.

Conclusion

Preserving fertility is a vital aspect of quality of life for young cancer survivors. By fostering open dialogues and integrating fertility preservation into standard oncology care, we can empower AYAs to envision a future that includes the possibility of building a family.

For personalized medical advice and to explore fertility preservation options, please consult with a qualified healthcare professional.

By Dr. Lina Akopians, MD, PhD, FACOG

For further reading on this topic click here.